Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association.

Jennifer Lewey, Theresa M Beckie, Haywood L Brown, Susan D Brown, Vesna D Garovic, Sadiya S Khan, Eliza C Miller, Garima Sharma, Laxmi S Mehta, American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; and Council on Cardiovascular and Stroke Nursing
Author Information

Abstract

Adverse pregnancy outcomes are common among pregnant individuals and are associated with long-term risk of cardiovascular disease. Individuals with adverse pregnancy outcomes also have an increased incidence of cardiovascular disease risk factors after delivery. Despite this, evidence-based approaches to managing these patients after pregnancy to reduce cardiovascular disease risk are lacking. In this scientific statement, we review the current evidence on interpregnancy and postpartum preventive strategies, blood pressure management, and lifestyle interventions for optimizing cardiovascular disease using the American Heart Association Life's Essential 8 framework. Clinical, health system, and community-level interventions can be used to engage postpartum individuals and to reach populations who experience the highest burden of adverse pregnancy outcomes and cardiovascular disease. Future trials are needed to improve screening of subclinical cardiovascular disease in individuals with a history of adverse pregnancy outcomes, before the onset of symptomatic disease. Interventions in the fourth trimester, defined as the 12 weeks after delivery, have great potential to improve cardiovascular health across the life course.

Keywords

References

  1. J Am Heart Assoc. 2021 Sep 7;10(17):e020138 [PMID: 34431309]
  2. Ultrasound Obstet Gynecol. 2020 Sep;56(3):329-339 [PMID: 32068930]
  3. J Headache Pain. 2022 Apr 12;23(1):34 [PMID: 35410119]
  4. J Am Coll Cardiol. 2022 Oct 11;80(15):1465-1476 [PMID: 36202536]
  5. Am J Obstet Gynecol. 2019 Sep;221(3):283-285 [PMID: 31121137]
  6. PLoS Med. 2020 Aug 14;17(8):e1003255 [PMID: 32797043]
  7. Hypertension. 2022 Feb;79(2):e21-e41 [PMID: 34905954]
  8. N Engl J Med. 2022 May 12;386(19):1781-1792 [PMID: 35363951]
  9. Obstet Gynecol. 2021 Feb 1;137(2):e54-e62 [PMID: 33481532]
  10. J Am Heart Assoc. 2020 Sep;9(17):e016357 [PMID: 32851901]
  11. Obstet Gynecol. 2009 May;113(5):974-982 [PMID: 19384111]
  12. Circulation. 2019 Jun 18;139(25):e1082-e1143 [PMID: 30586774]
  13. JAMA. 2023 Feb 7;329(5):393-404 [PMID: 36749333]
  14. J Am Heart Assoc. 2019 Oct;8(19):e013092 [PMID: 31564189]
  15. Mayo Clin Proc. 2019 Mar;94(3):536-543 [PMID: 30713048]
  16. J Clin Endocrinol Metab. 2018 Jul 1;103(7):2478-2487 [PMID: 29762737]
  17. J Matern Fetal Neonatal Med. 2022 Dec;35(25):7555-7561 [PMID: 34470135]
  18. Am J Prev Med. 2022 Nov;63(5):689-699 [PMID: 35840450]
  19. Diabetes Care. 2016 Jan;39(1):65-74 [PMID: 26657945]
  20. Arch Intern Med. 2004 Jan 12;164(1):97-102 [PMID: 14718329]
  21. Ann Fam Med. 2010 Jul-Aug;8(4):327-33 [PMID: 20644187]
  22. Hypertension. 2020 Mar;75(3):772-780 [PMID: 32008433]
  23. Eur Heart J. 2022 Sep 14;43(35):3352-3361 [PMID: 34643681]
  24. Circulation. 2021 May 4;143(18):e902-e916 [PMID: 33779213]
  25. Pediatrics. 2019 Jan;143(1): [PMID: 30559120]
  26. BMJ. 2017 Jul 12;358:j3078 [PMID: 28701333]
  27. Circulation. 2022 Aug 2;146(5):e18-e43 [PMID: 35766027]
  28. Circ Cardiovasc Imaging. 2020 Nov;13(11):e010340 [PMID: 33190533]
  29. Curr Atheroscler Rep. 2022 Sep;24(9):689-699 [PMID: 35781777]
  30. Circulation. 2019 Sep 24;140(13):1050-1060 [PMID: 31545680]
  31. Circulation. 2022 Feb 8;145(6):416-423 [PMID: 35130054]
  32. Hypertension. 2020 Jan;75(1):229-236 [PMID: 31786971]
  33. Transl Behav Med. 2021 Nov 30;11(11):1998-2008 [PMID: 34850927]
  34. Obstet Gynecol. 2019 Oct;134(4):685-691 [PMID: 31503166]
  35. Obstet Gynecol. 2018 Sep;132(3):784-785 [PMID: 30134408]
  36. J Diabetes Res. 2022 Feb 1;2022:2942918 [PMID: 35118160]
  37. Circulation. 2018 Jun 12;137(24):e843-e852 [PMID: 29748185]
  38. Stroke. 2023 Jul;54(7):1798-1805 [PMID: 37212139]
  39. Womens Health Issues. 2021 May-Jun;31(3):204-218 [PMID: 33707142]
  40. J Perinatol. 2016 Dec;36(12):1079-1082 [PMID: 27583396]
  41. J Womens Health (Larchmt). 2009 Oct;18(10):1661-7 [PMID: 19785567]
  42. Am J Obstet Gynecol. 2022 Feb;226(2S):S1211-S1221 [PMID: 35177218]
  43. Lancet. 2016 Aug 20;388(10046):761-75 [PMID: 27431356]
  44. Sleep Med Rev. 2018 Oct;41:87-100 [PMID: 29449122]
  45. J Womens Health (Larchmt). 2021 Feb;30(2):230-235 [PMID: 33181043]
  46. Circulation. 2022 Jan 25;145(4):e117-e128 [PMID: 34847691]
  47. J Am Coll Cardiol. 2022 Mar 1;79(8):819-836 [PMID: 35210038]
  48. JAMA Cardiol. 2019 Jul 1;4(7):628-635 [PMID: 31188397]
  49. JAMA Netw Open. 2020 Dec 1;3(12):e2030815 [PMID: 33351087]
  50. J Womens Health (Larchmt). 2020 May;29(5):627-635 [PMID: 31800357]
  51. BMJ Qual Saf. 2018 Nov;27(11):871-877 [PMID: 29703800]
  52. Hypertension. 2018 Mar;71(3):491-498 [PMID: 29437895]
  53. Am J Med. 2009 Jul;122(7):656-63.e1 [PMID: 19559168]
  54. Obstet Gynecol. 2020 May;135(5):e221-e229 [PMID: 32332417]
  55. J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9 [PMID: 18826999]
  56. Am J Obstet Gynecol. 2014 Nov;211(5):516.e1-516.e11 [PMID: 24769012]
  57. Obstet Gynecol. 2019 Jan;133(1):e26-e50 [PMID: 30575676]
  58. J Pak Med Assoc. 2018 Apr;68(4):548-553 [PMID: 29808043]
  59. Eur Heart J. 2008 Apr;29(7):932-40 [PMID: 18334475]
  60. Hypertension. 2018 Jun;71(6):e13-e115 [PMID: 29133356]
  61. Obstet Gynecol. 2018 Nov;132(5):e208-e212 [PMID: 30629567]
  62. Obstet Gynecol Clin North Am. 2018 Jun;45(2):233-247 [PMID: 29747728]
  63. BMJ. 2019 Sep 9;366:l5119 [PMID: 31501137]
  64. BMJ Open Diabetes Res Care. 2022 Jun;10(3): [PMID: 35725017]
  65. J Womens Health (Larchmt). 2019 Nov;28(11):1493-1504 [PMID: 31215837]
  66. Am J Clin Nutr. 2016 Aug;104(2):362-70 [PMID: 27413127]
  67. Hypertension. 2021 Jun;77(6):e58-e67 [PMID: 33910363]
  68. Am J Prev Med. 2021 Jul;61(1):44-54 [PMID: 33994252]
  69. JAMA Netw Open. 2023 Feb 1;6(2):e2254765 [PMID: 36745454]
  70. Hypertension. 2018 Jan;71(1):103-109 [PMID: 29133363]
  71. Headache. 2022 Oct;62(9):1198-1206 [PMID: 36073865]
  72. J Clin Sleep Med. 2018 Apr 15;14(4):549-555 [PMID: 29609706]
  73. Matern Health Neonatol Perinatol. 2017 Dec 04;3:20 [PMID: 29214042]
  74. Circulation. 2021 Oct 12;144(15):e251-e269 [PMID: 34493059]
  75. Am J Prev Cardiol. 2022 Nov 13;12:100430 [PMID: 36439649]
  76. Stroke. 2017 Feb;48(2):e44-e71 [PMID: 27980126]
  77. Diabetes Care. 2023 Jan 1;46(Suppl 1):S254-S266 [PMID: 36507645]
  78. Circulation. 2021 Feb 16;143(7):761-763 [PMID: 33587655]
  79. Obstet Gynecol. 2020 Jun;135(6):e237-e260 [PMID: 32443079]
  80. Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007643 [PMID: 33563007]
  81. Circulation. 2021 Feb 16;143(7):727-738 [PMID: 33587666]
  82. JAMA Cardiol. 2022 Jun 1;7(6):591-599 [PMID: 35442393]
  83. J Clin Hypertens (Greenwich). 2013 Sep;15(9):617-23 [PMID: 24034653]
  84. Lancet. 1987 Aug 8;2(8554):330 [PMID: 2886783]
  85. JAMA. 2016 Jan 26;315(4):380-7 [PMID: 26813211]
  86. Obstet Gynecol. 2019 Jan;133(1):e51-e72 [PMID: 30575677]
  87. Int J Obes Relat Metab Disord. 2003 Jan;27(1):117-27 [PMID: 12532163]
  88. J Womens Health (Larchmt). 2022 Aug;31(8):1165-1172 [PMID: 35172115]
  89. Nutr Metab Cardiovasc Dis. 2014 Feb;24(2):107-15 [PMID: 24439841]
  90. Obesity (Silver Spring). 2019 Apr;27(4):535-541 [PMID: 30900408]
  91. Obstet Gynecol. 2023 Jun 1;141(6):1163-1170 [PMID: 37486653]
  92. J Am Coll Cardiol. 2019 Dec 3;74(22):2743-2754 [PMID: 31727424]
  93. Circulation. 2015 Nov 3;132(18):1726-33 [PMID: 26416810]
  94. Curr Diab Rep. 2019 Aug 5;19(9):78 [PMID: 31385061]
  95. Hypertension. 2021 May 5;77(5):1517-1524 [PMID: 33550824]
  96. Hypertens Pregnancy. 2017 Feb;36(1):44-47 [PMID: 27786578]
  97. Diabetes Care. 2020 Nov 2;: [PMID: 33139407]
  98. Circulation. 2019 Sep 10;140(11):e596-e646 [PMID: 30879355]
  99. Am J Health Promot. 2018 Feb;32(2):464-472 [PMID: 29092630]
  100. Hypertension. 2018 Aug;72(2):425-432 [PMID: 29967037]
  101. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103 [PMID: 27467196]
  102. J Am Coll Cardiol. 2021 Mar 2;77(8):1057-1068 [PMID: 33632480]
  103. Obstet Gynecol. 2018 Jul;132(1):e44-e52 [PMID: 29939940]
  104. J Acad Nutr Diet. 2018 Jul;118(7):1196-1207 [PMID: 29396153]
  105. Obstet Gynecol. 2014 Sep;124(3):563-570 [PMID: 25162257]
  106. Circ Res. 2022 Mar 4;130(5):782-799 [PMID: 35239404]
  107. JAMA. 2017 Jun 20;317(23):2381-2391 [PMID: 28632867]
  108. Obstet Gynecol. 2018 Feb;131(2):e49-e64 [PMID: 29370047]
  109. Pregnancy Hypertens. 2022 Dec;30:31-35 [PMID: 35961183]
  110. Lancet Neurol. 2018 Jul;17(7):641-650 [PMID: 29914709]
  111. Circulation. 2020 Jun 9;141(23):e884-e903 [PMID: 32362133]
  112. Int J Obes (Lond). 2021 Aug;45(8):1728-1739 [PMID: 34021264]
  113. Obesity (Silver Spring). 2022 Jul;30(7):1370-1379 [PMID: 35722816]
  114. J Am Coll Cardiol. 2019 Apr 30;73(16):2106-2116 [PMID: 31023435]
  115. Diabetes Res Clin Pract. 2021 Jan;171:108625 [PMID: 33333204]
  116. BMJ. 2007 Nov 10;335(7627):974 [PMID: 17975258]
  117. Arteriosclerosis. 1984 Jul-Aug;4(4):407-17 [PMID: 6431954]

Grants

  1. R01 NS122815/NINDS NIH HHS
  2. UG3 OD035540/NIH HHS
  3. K23 HL153667/NHLBI NIH HHS
  4. K23 NS107645/NINDS NIH HHS
  5. R21 AG069111/NIA NIH HHS
  6. R21 HD110992/NICHD NIH HHS
  7. P30 DK092924/NIDDK NIH HHS
  8. R01 DK118455/NIDDK NIH HHS
  9. KL2 TR003099/NCATS NIH HHS
  10. K26 DK138246/NIDDK NIH HHS
  11. R01 HL142996/NHLBI NIH HHS
  12. R01 DK122087/NIDDK NIH HHS

MeSH Term

Pregnancy
Female
United States
Humans
Cardiovascular Diseases
American Heart Association
Postpartum Period
Pregnancy Outcome
Blood Pressure
Risk Factors

Word Cloud

Created with Highcharts 10.0.0cardiovascularpregnancydiseaseoutcomesindividualsriskadversepostpartumAdversedeliveryinterventionsAmericanHeartAssociationhealthimproveScientificcommonamongpregnantassociatedlong-termIndividualsalsoincreasedincidencefactorsDespiteevidence-basedapproachesmanagingpatientsreducelackingscientificstatementreviewcurrentevidenceinterpregnancypreventivestrategiesbloodpressuremanagementlifestyleoptimizingusingLife'sEssential8frameworkClinicalsystemcommunity-levelcanusedengagereachpopulationsexperiencehighestburdenFuturetrialsneededscreeningsubclinicalhistoryonsetsymptomaticInterventionsfourthtrimesterdefined12weeksgreatpotentialacrosslifecourseOpportunitiesPostpartumPeriodReduceCardiovascularDiseaseRiskPregnancyOutcomes:StatementAHAStatementsdiseasesdiabetesgestationalperiodcomplicationsprimaryprevention

Similar Articles

Cited By